Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort study

Abstract Background Long COVID, a highly heterogeneous syndrome affecting millions of people worldwide, is emerging as an urgent public health threat, but data on the predictors of specific clinical manifestations over long follow-up periods are limited. The aim of this study is to investigate the r...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesco Di Gennaro, Nicola Veronese, Francesco Vladimiro Segala, Luisa Frallonardo, Giacomo Guido, Mariangela Cormio, Greta Romita, Angela Parisi, Eliana Marrone, Maria Elena Ciuppa, Anna La Carrubba, Luca Carruba, Anna Licata, Giada Cavallaro, Vittorio Pagliuso, Teresa Maino, Silvia Lollo, Lorenzo Latino, Lidia Tina Solimeo, Antonia Ianniello, Domenico Montalbò, Davide Fiore Bavaro, Maria Luisa Fiorella, Mario Barbagallo, Annalisa Saracino
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-024-10226-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846158729977790464
author Francesco Di Gennaro
Nicola Veronese
Francesco Vladimiro Segala
Luisa Frallonardo
Giacomo Guido
Mariangela Cormio
Greta Romita
Angela Parisi
Eliana Marrone
Maria Elena Ciuppa
Anna La Carrubba
Luca Carruba
Anna Licata
Giada Cavallaro
Vittorio Pagliuso
Teresa Maino
Silvia Lollo
Lorenzo Latino
Lidia Tina Solimeo
Antonia Ianniello
Domenico Montalbò
Davide Fiore Bavaro
Maria Luisa Fiorella
Mario Barbagallo
Annalisa Saracino
author_facet Francesco Di Gennaro
Nicola Veronese
Francesco Vladimiro Segala
Luisa Frallonardo
Giacomo Guido
Mariangela Cormio
Greta Romita
Angela Parisi
Eliana Marrone
Maria Elena Ciuppa
Anna La Carrubba
Luca Carruba
Anna Licata
Giada Cavallaro
Vittorio Pagliuso
Teresa Maino
Silvia Lollo
Lorenzo Latino
Lidia Tina Solimeo
Antonia Ianniello
Domenico Montalbò
Davide Fiore Bavaro
Maria Luisa Fiorella
Mario Barbagallo
Annalisa Saracino
author_sort Francesco Di Gennaro
collection DOAJ
description Abstract Background Long COVID, a highly heterogeneous syndrome affecting millions of people worldwide, is emerging as an urgent public health threat, but data on the predictors of specific clinical manifestations over long follow-up periods are limited. The aim of this study is to investigate the role of viral variants and other predictors in long COVID incidence and clinical manifestations. Methods All COVID-19 patients aged > 18 years and hospitalized from March 1 2020 to April 2022 in two Italian University Hospitals were enrolled. Incidence and clinical presentation of long COVID were assessed through structured questionnaires delivered by phone calls. The association between possible risk factors collected during hospitalization and long COVID was reported using an adjusted logistic regression and reported as odds ratios (ORs) with their 95% confidence intervals (CIs). Results Among 1,012 recruited patients, over a median follow-up of 19 months (IQR: 15–24 months), the cumulative incidence of long COVID was 91.7%, with the most common clinical manifestations involving the respiratory system (80.5%) and the neurological system (77.3%). Among 1,012 recruited patients, over a median follow-up of 19 months (IQR: 15–24 months), the cumulative incidence of long COVID was 91.7%, with the most common clinical manifestations involving the respiratory system (80.5%) and the neurological system (77.3%). Overall, 54% reported long COVID symptomatology between 18 and 24 months. Multivariate analysis suggested that being vaccinated against SARS-CoV-2 was associated with reduced odds of reporting any long COVID symptomatology (OR: 0.34; 95% CI: 0.21–0.58), while infection with the Delta variant was a strong predictor (OR: 9.61, p < 0.0001) for the development of post-COVID conditions characterized by neuropsychiatric symptoms. Conclusions In this study long COVID symptoms were still highly prevalent after 18–24 months of follow-up and, when compared to wild-type virus, infection with the Delta variant was associated with a higher risk of developing a neurological post-COVID condition.
format Article
id doaj-art-4792f019bc1d477fbbffbbc727a2cf77
institution Kabale University
issn 1471-2334
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-4792f019bc1d477fbbffbbc727a2cf772024-11-24T12:12:56ZengBMCBMC Infectious Diseases1471-23342024-11-0124111010.1186/s12879-024-10226-1Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort studyFrancesco Di Gennaro0Nicola Veronese1Francesco Vladimiro Segala2Luisa Frallonardo3Giacomo Guido4Mariangela Cormio5Greta Romita6Angela Parisi7Eliana Marrone8Maria Elena Ciuppa9Anna La Carrubba10Luca Carruba11Anna Licata12Giada Cavallaro13Vittorio Pagliuso14Teresa Maino15Silvia Lollo16Lorenzo Latino17Lidia Tina Solimeo18Antonia Ianniello19Domenico Montalbò20Davide Fiore Bavaro21Maria Luisa Fiorella22Mario Barbagallo23Annalisa Saracino24Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J) - Clinic of Infectious Diseases, University of Bari “Aldo Moro”Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G. D’Alessandro”, University of PalermoDepartment of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J) - Clinic of Infectious Diseases, University of Bari “Aldo Moro”Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J) - Clinic of Infectious Diseases, University of Bari “Aldo Moro”Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J) - Clinic of Infectious Diseases, University of Bari “Aldo Moro”Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J) - Clinic of Infectious Diseases, University of Bari “Aldo Moro”Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J) - Clinic of Infectious Diseases, University of Bari “Aldo Moro”Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G. D’Alessandro”, University of PalermoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G. D’Alessandro”, University of PalermoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G. D’Alessandro”, University of PalermoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G. D’Alessandro”, University of PalermoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G. D’Alessandro”, University of PalermoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G. D’Alessandro”, University of PalermoOtolaryngology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari “Aldo Moro”Otolaryngology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari “Aldo Moro”Otolaryngology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari “Aldo Moro”Otolaryngology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari “Aldo Moro”Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J) - Clinic of Infectious Diseases, University of Bari “Aldo Moro”Otolaryngology Unit, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari “Aldo Moro”Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G. D’Alessandro”, University of PalermoDepartment of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J) - Clinic of Infectious Diseases, University of Bari “Aldo Moro”Abstract Background Long COVID, a highly heterogeneous syndrome affecting millions of people worldwide, is emerging as an urgent public health threat, but data on the predictors of specific clinical manifestations over long follow-up periods are limited. The aim of this study is to investigate the role of viral variants and other predictors in long COVID incidence and clinical manifestations. Methods All COVID-19 patients aged > 18 years and hospitalized from March 1 2020 to April 2022 in two Italian University Hospitals were enrolled. Incidence and clinical presentation of long COVID were assessed through structured questionnaires delivered by phone calls. The association between possible risk factors collected during hospitalization and long COVID was reported using an adjusted logistic regression and reported as odds ratios (ORs) with their 95% confidence intervals (CIs). Results Among 1,012 recruited patients, over a median follow-up of 19 months (IQR: 15–24 months), the cumulative incidence of long COVID was 91.7%, with the most common clinical manifestations involving the respiratory system (80.5%) and the neurological system (77.3%). Among 1,012 recruited patients, over a median follow-up of 19 months (IQR: 15–24 months), the cumulative incidence of long COVID was 91.7%, with the most common clinical manifestations involving the respiratory system (80.5%) and the neurological system (77.3%). Overall, 54% reported long COVID symptomatology between 18 and 24 months. Multivariate analysis suggested that being vaccinated against SARS-CoV-2 was associated with reduced odds of reporting any long COVID symptomatology (OR: 0.34; 95% CI: 0.21–0.58), while infection with the Delta variant was a strong predictor (OR: 9.61, p < 0.0001) for the development of post-COVID conditions characterized by neuropsychiatric symptoms. Conclusions In this study long COVID symptoms were still highly prevalent after 18–24 months of follow-up and, when compared to wild-type virus, infection with the Delta variant was associated with a higher risk of developing a neurological post-COVID condition.https://doi.org/10.1186/s12879-024-10226-1Long COVIDPost-acute sequelae of COVID-19COVID-19 vaccinationDelta variantOmicron variant
spellingShingle Francesco Di Gennaro
Nicola Veronese
Francesco Vladimiro Segala
Luisa Frallonardo
Giacomo Guido
Mariangela Cormio
Greta Romita
Angela Parisi
Eliana Marrone
Maria Elena Ciuppa
Anna La Carrubba
Luca Carruba
Anna Licata
Giada Cavallaro
Vittorio Pagliuso
Teresa Maino
Silvia Lollo
Lorenzo Latino
Lidia Tina Solimeo
Antonia Ianniello
Domenico Montalbò
Davide Fiore Bavaro
Maria Luisa Fiorella
Mario Barbagallo
Annalisa Saracino
Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort study
BMC Infectious Diseases
Long COVID
Post-acute sequelae of COVID-19
COVID-19 vaccination
Delta variant
Omicron variant
title Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort study
title_full Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort study
title_fullStr Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort study
title_full_unstemmed Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort study
title_short Protective role of vaccination on the development of long COVID: data from a large, multicenter, prospective cohort study
title_sort protective role of vaccination on the development of long covid data from a large multicenter prospective cohort study
topic Long COVID
Post-acute sequelae of COVID-19
COVID-19 vaccination
Delta variant
Omicron variant
url https://doi.org/10.1186/s12879-024-10226-1
work_keys_str_mv AT francescodigennaro protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT nicolaveronese protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT francescovladimirosegala protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT luisafrallonardo protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT giacomoguido protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT mariangelacormio protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT gretaromita protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT angelaparisi protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT elianamarrone protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT mariaelenaciuppa protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT annalacarrubba protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT lucacarruba protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT annalicata protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT giadacavallaro protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT vittoriopagliuso protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT teresamaino protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT silvialollo protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT lorenzolatino protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT lidiatinasolimeo protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT antoniaianniello protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT domenicomontalbo protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT davidefiorebavaro protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT marialuisafiorella protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT mariobarbagallo protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy
AT annalisasaracino protectiveroleofvaccinationonthedevelopmentoflongcoviddatafromalargemulticenterprospectivecohortstudy